Suppr超能文献

利用DNA微阵列技术鉴定不同类型肺癌中的特征性生物标志物。

Identification of featured biomarkers in different types of lung cancer with DNA microarray.

作者信息

Zhou Chao, Chen Hao, Han Li, Wang An, Chen Liang-An

机构信息

Department of Respiratory Medicine, Zhou Pu Hospital, 1500 Zhouyuan Road, Pudong new District, Shanghai, 201318, China,

出版信息

Mol Biol Rep. 2014 Oct;41(10):6357-63. doi: 10.1007/s11033-014-3515-9. Epub 2014 Jul 8.

Abstract

Lung cancer is a worldwide leading cause of cancer-related death. The aim of this study was to identify target genes and specific biomarkers for identification and treatment of different types of lung cancer with DNA microarray. Gene expression profile GSE6044 and miRNA microarray profile GSE17681 were downloaded from Gene Expression Omnibus database. The differentially expressed genes (DEGs) and miRNAs were screened with multtest package in R language. Then, functional enrichment analysis of identified DEGs was performed. Furthermore, the verified target genes based on screened miRNAs were selected from miRTarBase and miRecords databases. Then miRNA-target gene regulation network was constructed. APOE, CDC6 and ATP2B1were involved in most of the functions obtained for adenocarcinomas, small cell lung cancer and squamous cell carcinomas, respectively. The target DEGs of differentially expressed hsa-miR-29a included FGG in adenocarcinoma, RAN and COL4A1 in small cell lung cancer, GLUL in squamous cell carcinoma. The target DEGs of has-miR-7 were SNCA and SLC7A5 in adenocarcinoma and small cell lung cancer, respectively. ICAM1 and KIT were the target DEGs of hsa-miR-222 in adenocarcinoma and squamous cell carcinoma. The miRNAs and their differentially expressed target genes have the potential to be used in clinic for diagnosis and treatment of different kinds of lung cancer in the future.

摘要

肺癌是全球癌症相关死亡的主要原因。本研究旨在通过DNA微阵列鉴定不同类型肺癌的靶基因和特异性生物标志物,用于肺癌的诊断和治疗。从基因表达综合数据库下载基因表达谱GSE6044和miRNA微阵列谱GSE17681。使用R语言中的multtest软件包筛选差异表达基因(DEG)和miRNA。然后,对鉴定出的DEG进行功能富集分析。此外,从miRTarBase和miRecords数据库中选择基于筛选出的miRNA的验证靶基因。然后构建miRNA-靶基因调控网络。APOE、CDC6和ATP2B1分别参与了腺癌、小细胞肺癌和鳞状细胞癌的大部分功能。差异表达的hsa-miR-29a的靶DEG在腺癌中为FGG,在小细胞肺癌中为RAN和COL4A1,在鳞状细胞癌中为GLUL。has-miR-7的靶DEG在腺癌和小细胞肺癌中分别为SNCA和SLC7A5。ICAM1和KIT是hsa-miR-222在腺癌和鳞状细胞癌中的靶DEG。这些miRNA及其差异表达的靶基因未来有可能用于临床诊断和治疗不同类型的肺癌。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验